Nothing Special   »   [go: up one dir, main page]

Ma et al., 2020 - Google Patents

[12] aneN3-based gemini-type amphiphiles with two-photon absorption properties for enhanced nonviral gene delivery and bioimaging

Ma et al., 2020

Document ID
1308799328574708990
Author
Ma L
Tang Q
Liu M
Liu X
Liu J
Lu Z
Gao Y
Wang R
Publication year
Publication venue
ACS Applied Materials & Interfaces

External Links

Snippet

Although a plethora of nonviral gene vectors have been developed for potential gene therapy, imageable gemini surfactants with stimuli-responsiveness and high transfection efficiency are still scarce for gene delivery. Herein, three gemini amphiphiles (DEDPP …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
    • A61K47/48061—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a heterocyclic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Similar Documents

Publication Publication Date Title
Ma et al. [12] aneN3-based gemini-type amphiphiles with two-photon absorption properties for enhanced nonviral gene delivery and bioimaging
Kang et al. Reactive oxygen species and glutathione dual redox-responsive supramolecular assemblies with controllable release capability
Tang et al. Two-photon near-infrared AIE luminogens as multifunctional gene carriers for cancer theranostics
Gabrielson et al. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions
Chen et al. Theranostic prodrug vesicles for imaging guided codelivery of camptothecin and siRNA in synergetic cancer therapy
Grandinetti et al. Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?
Liu et al. New poly (D-glucaramidoamine) s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells
Zhao et al. Folic acid modified cationic γ-cyclodextrin-oligoethylenimine star polymer with bioreducible disulfide linker for efficient targeted gene delivery
Méndez-Ardoy et al. β-Cyclodextrin-based polycationic amphiphilic “click” clusters: Effect of structural modifications in their DNA complexing and delivery properties
Bagnacani et al. Lower rim guanidinocalix [4] arenes: macrocyclic nonviral vectors for cell transfection
Grandinetti et al. Exploring the mechanism of plasmid DNA nuclear internalization with polymer-based vehicles
Tambe et al. Triptorelin tethered multifunctional PAMAM-histidine-PEG nanoconstructs enable specific targeting and efficient gene silencing in LHRH overexpressing cancer cells
Giron-Gonzalez et al. Polyelectrolyte complexes of low molecular weight PEI and citric acid as efficient and nontoxic vectors for in vitro and in vivo gene delivery
Li et al. Engineering the aromaticity of cationic helical polypeptides toward “self-activated” DNA/siRNA delivery
Gao et al. Synthesis of 6-N, N, N-trimethyltriazole chitosan via “click chemistry” and evaluation for gene delivery
Ding et al. Gemini-type tetraphenylethylene amphiphiles containing [12] aneN3 and long hydrocarbon chains as nonviral gene vectors and gene delivery monitors
Wang et al. Reduction-degradable linear cationic polymers as gene carriers prepared by Cu (I)-catalyzed azide− alkyne cycloaddition
Layek et al. Cell penetrating peptide conjugated polymeric micelles as a high performance versatile nonviral gene carrier
Liu et al. Combination of [12] aneN3 and triphenylamine-benzylideneimidazolone as nonviral gene vectors with two-photon and AIE properties
Zhang et al. Redox-responsive and dual-targeting hyaluronic acid–methotrexate prodrug self-assembling nanoparticles for enhancing intracellular drug self-delivery
Sun et al. Tumor targeting gene vector for visual tracking of Bcl-2 siRNA transfection and anti-tumor therapy
Martínez et al. Amphiphilic Oligoethyleneimine− β-Cyclodextrin “Click” Clusters for Enhanced DNA Delivery
Liu et al. Vitamin E-Labeled Polyethylenimine for in vitro and in vivo Gene Delivery
Zhou et al. Tailoring the supramolecular structure of guanidinylated pullulan toward enhanced genetic photodynamic therapy
Tang et al. A NIR aggregation-induced emission fluoroamphiphile as visually trackable and serum-tolerant nonviral gene carrier